The calcium‐sensing receptor: A novel target for treatment and prophylaxis of neratinib‐induced diarrhea
Author:
Affiliation:
1. Department of Surgery Yale University School of Medicine New Haven CT USA
2. Puma Biotechnology, Inc. Los Angeles CA USA
3. Department of Cellular and Molecular Physiology Yale University School of Medicine New Haven CT USA
Funder
Yale University
Publisher
Wiley
Subject
General Pharmacology, Toxicology and Pharmaceutics,Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.521
Reference39 articles.
1. Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase
2. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3. Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor
4. NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
5. Antitumor activity of HER-2 inhibitors
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mg2+ supplementation treats secretory diarrhea in mice by activating calcium-sensing receptor in intestinal epithelial cells;Journal of Clinical Investigation;2024-01-16
2. Targeted therapy for breast cancer: An overview of drug classes and outcomes;Biochemical Pharmacology;2022-10
3. Calcium-sensing receptor acts as an antiviral factor for rotavirus infections and participates in cellular antiviral response;IRAN J BASIC MED SCI;2022
4. Colonic Fluid and Electrolyte Transport 2022: An Update;Cells;2022-05-22
5. Neratinib causes non-recoverable gut injury and reduces intestinal cytochrome P450 3A enzyme in mice;Toxicology Research;2022-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3